Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
Age
18–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Must be prescribed AVONEX PEN as per local labeling (Product Monograph) and enrolled in MS Alliance (MSA) program
If being switched from another DMT, must be on this DMT for at least 6 months
Last DMT the subject is switched from must be injectable
Must be able to physically demonstrate use of the AVONEX PEN autoinjector device and be able to self-administer the injections
Must give written informed consent. If required by local law, candidates must also authorize the release and use of protected health information (PHI)
Must be able to understand and comply with the protocol
You may not be if
Female subjects considering becoming pregnant while in the study or who are currently pregnant or breast-feeding
Current enrollment in any investigational study involving drug, biologic or non-drug therapy
Participation in other clinical studies within the past 6 months
Treatment with immunosuppressive regimens (e.g. cyclophosphamide, azathioprine, methotrexate or mitoxantrone) or with intravenous immunoglobulin (IVIg) in the last 6 months
The most recent DMT the subject is switched from is non-injectable (i.e., oral)
Other unspecified reasons that, in the opinion of the Investigator or Sponsor, make the subject unsuitable for enrollment
